Fred Alger Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-4,907,570
Closed -$235M – 463
2026
Q2
$235M Buy
+4,907,570
New +$211M 0.78% 23
2024
Q4
– Sell
-31
Closed -$3.69K – 455
2024
Q3
$3.69K Sell
31
-54,462
-100% -$7.26M ﹤0.01% 429
2024
Q2
$7.78M Buy
54,493
+15,129
+38% +$2M 0.04% 209
2024
Q1
$5.05M Buy
39,364
+16,599
+73% +$1.98M 0.03% 254
2023
Q4
$2.36M Buy
22,765
+22,733
+71,041% +$2.25M 0.01% 311
2023
Q3
$2.91K Hold
32
– – ﹤0.01% 455
2023
Q2
$2.59K Buy
32
+4
+14% +$327 ﹤0.01% 508
2023
Q1
$2.23K Buy
+28
New +$1.98K ﹤0.01% 506
2020
Q4
– Sell
-53,598
Closed -$1.86M – 493
2020
Q3
$1.86M Sell
53,598
-12,402
-19% -$413K 0.01% 307
2020
Q2
$2.16M Buy
66,000
+6,000
+10% +$191K 0.01% 301
2020
Q1
$1.81M Buy
+60,000
New +$1.79M 0.01% 284
2019
Q2
– Sell
-28,000
Closed -$732K – 543
2019
Q1
$732K Buy
+28,000
New +$688K ﹤0.01% 354
2018
Q4
– Sell
-90,000
Closed -$2.12M – 557
2018
Q3
$2.12M Hold
90,000
– – 0.01% 280
2018
Q2
$2.08M Buy
90,000
+2,000
+2% +$47.5K 0.01% 279
2018
Q1
$2.17M Buy
88,000
+8,000
+10% +$210K 0.01% 288
2017
Q4
$2.15M Buy
80,000
+4,000
+5% +$102K 0.01% 284
2017
Q3
$1.83M Buy
76,000
+24,000
+46% +$542K 0.01% 286
2017
Q2
$1.12M Buy
+52,000
New +$1.05M 0.01% 329
2016
Q4
– Sell
-34,000
Closed -$707K – 509
2016
Q3
$707K Sell
34,000
-1,700
-5% -$42.1K ﹤0.01% 329
2016
Q2
$960K Buy
35,700
+12,100
+51% +$332K 0.01% 332
2016
Q1
$639K Sell
23,600
-48,800
-67% -$1.31M ﹤0.01% 400
2015
Q4
$2.1M Sell
72,400
-17,000
-19% -$471K 0.01% 329
2015
Q3
$2.42M Hold
89,400
– – 0.01% 334
2015
Q2
$2.45M Buy
+89,400
New +$2.51M 0.01% 372

Other funds holding NVO

Fred Alger Management's NVO Position: Q3 2026 in Review

Fred Alger Management sold out of Novo Nordisk (NVO) in Q3 2026, closing a stake of 4,907,570 shares — an estimated $235M sold.

Fred Alger Management first reported a position in NVO in Q2 2015 and held it in 24 quarters. The position peaked at $235M in Q2 2026. 1,215 funds tracked by Wall St. Rank hold NVO as of Q3 2026.

  • Fred Alger Management reported no remaining Novo Nordisk position as of Q3 2026 after selling out during the quarter.
  • Fred Alger Management sold 4,907,570 Novo Nordisk shares in Q3 2026, an estimated $235M.
  • Fred Alger Management first reported a position in Novo Nordisk in Q2 2015 and held it in 24 quarters.
  • Fred Alger Management's Novo Nordisk position peaked at $235M in Q2 2026.
  • 1,215 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2026.

Based on Fred Alger Management's 13F filing for Q3 2026, filed 16 Nov 2026.